Collateral for a security interest recorded Jan 13, 2025 (Symbiotic Capital Agency LLC).
Term ends Apr 24, 2040 · Medium confidence
20-year base term ends Jun 27, 2037
Why Medium: A parent in the chain could not be resolved.
Held by Galary, Inc.
Filed Mar 25, 2021 as application 17/212,833 · Granted Sep 2, 2025
Base term plus 1032 days of patent term adjustment (USPTO delay)
Today
2017
2040
Clock starts
Jun 27, 2017
Jun 27, 2017
Term ends
Apr 24, 2040
Apr 24, 2040
Granted
Sep 2, 2025
Sep 2, 2025
base term
patent term adjustment
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,032
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
21
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1032 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 27, 2017, when application PCT/US2017/039527, the earliest non-provisional in its chain, was filed (this one was filed Mar 25, 2021); a parent in its chain could not be resolved (the next row) | Jun 27, 2037 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +1032 days, USPTO patent term adjustment record | Apr 24, 2040 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 24, 2040 | Medium confidence |
This family
| US 11,369,433 | In force Jun 2037 | Jun 2037 |
| US 10,702,337 | In force Jun 2037 | Jun 2037 |
| Application PCT/US2020/028844 | PCT application no patent term | no patent term |
| US 10,939,958 | In force Jun 2037 | Jun 2037 |
| US 11,471,208 | In force Dec 2038 | Dec 2038 |
| US 12,403,305 | this patent Apr 2040 | Apr 2040 |
| US 11,324,543 | In force Dec 2038 | Dec 2038 |
| US 12,599,432 | In force Apr 2040 | Apr 2040 |
8 of 21 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 6, 2023 Reel 64820, frame 166 | Waldstreicher, Jonathan R.; Krimsky, William S.; Neal, Robert E., II; Zarins, Denise M.; Beetel, Robert J.; Friedrichs, Paul Brian; Taylor, Kevin James; Turovskiy, Roman | Galary, Inc. | Assignment of Assignor's Interest |
| Sep 6, 2023 Reel 64820, frame 193 | Galary, Inc. | Galvanize Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 30, 2024 Reel 68455, frame 593 | Waldstreicher, Jonathan Reuben; Krimsky, William Sanford; Zarins, Denise Marie; Beetel, Robert J., III; Friedrichs, Paul Brian; Taylor, Kevin James; Turovskiy, Roman; Long, Gary L. | Gala Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 30, 2024 Reel 68455, frame 699 | Gala Therapeutics, Inc. | Galary, Inc. | Assignment of Assignor's Interest |
| Jan 13, 2025 Reel 69879, frame 694 | Galvanize Therapeutics, Inc. | Symbiotic Capital Agency LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2040
Term ends Apr 24, 2040. Maintenance fees still fall due before then
Note
The 1032 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
14
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.